Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. Administration FaD (2017) Value and use of patient-reported outcomes (PROs) in assessing effects of medical devices CDRH strategic priorities. [Available from: https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHVisionandMission/UCM588576.pdf. Accessed 2/4/23
2. Rivera SC, Kyte DG, Aiyegbusi OL, Slade AL, McMullan C, Calvert MJJH et al (2019) The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis. Health Qual Life Outcomes 17(1):1–19
3. Appleby J, Devlin N, Parkin D (2015) Using patient reported outcomes to improve health care. Wiley
4. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O’Fallon JR, Mahoney MR et al (1998) Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol 16(11):3662–3673
5. Kardinal CG, Loprinzi CL, Schaid DJ, Hass AC, Dose AM, Athmann LM et al (1990) A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer 65(12):2657–2662
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献